Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
TOI
$6.20
+0.65%
TOI · Oncology Institute, Inc.
$6.20
+0.04 (+0.65%)
At close · Aug 11
Market Cap
$522.83M
Shares
101.92M
All earnings calls
Earnings call · FY2026 Q2
Oncology Institute, Inc. Q2 FY2026 Earnings Call
Oncology Institute, Inc. Q2 FY2026 Earnings Call
Forward guidance
6 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$161.28M
+34.6% YoY
Diluted EPS
-$0.08
Net income
-$9.79M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 6, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue
table
Fiscal Year 2026
|
$650M – $670M | — | |
|
Gross Profit
table
Fiscal Year 2026
|
$105M – $110M | — | |
|
Adjusted EBITDA
table
Fiscal Year 2026
|
$2M – $7M | Non-GAAP | |
|
Capitated revenue
Fiscal Year 2026
|
$150M | — | |
|
Medical Loss Ratio
next twelve months
|
80% – 90% | Non-GAAP | |
|
Adjusted EBITDA
Third Quarter of 2026
|
$500,000 – $1.5M | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document